T-Regs, the Immune System and IκBNS, FOXP3, NfKB

Traffic Cops of the Immune System

Molecule called IκBNS in charge of regulatory immune cell maturation

http://www.helmholtz-hzi.de/en/news_events/news/view/article/complete/traffic_cops_of_the_immune_system/

A certain type of immune cell – the regulatory T cell, or Treg for short – is in charge of putting on the brakes on the immune response. In a way, this cell type might be considered the immune system’s traffic cop. Now, scientists at the Helmholtz Centre for Infection Research (HZI) have looked into the origin of Tregs and uncovered a central role played by the protein IκBNS. Armed with this knowledge, the researchers hope to manipulate Tregs in order to either inhibit or activate the immune system. Biochemist Prof. Ingo Schmitz and his team have now published their findings in the scientific journal Immunity.

The immune system is a complex network of different types of cells and chemical messengers. The regulatory cells and other immune cells exist together in a delicate balance. Any disturbance of this balance could have serious consequences: If there are too many Tregs, the immune system might be “thwarted” and little would stand in the way of infections or tumors spreading throughout the body.

By contrast, if there are too few Tregs, other immune cells could get out of control and attack the body’s own tissues: autoimmune diseases like rheumatoid arthritis or the chronic inflammatory bowel disease ulcerative colitis may be a consequence. Tregs also play an important role following an organ transplant as they decide whether the body will accept or reject the donor organ.

But what it is exactly that makes immature immune cells choose the “police officer career” had eluded scientists. Schmitz and his team from the HZI, the Otto von Guericke University Magdeburg, the Charité Universitätsmedizin Berlin, the Harvard Medical School Boston, the TWINCORE in Hanover, the Eberhard Karls University Tübingen and the Heinrich Heine University Düsseldorf were now able to demonstrate that the transcription factor IκBNS contributes considerably to Treg development.

The molecule promotes formation of the protein Foxp3, the Tregs’ central feature. IκBNS influences the large NFκB family of transcription factors. These signaling molecules trigger a number of different inflammatory responses elicited by the immune system. “It was therefore all the more surprising for us when we identified IκBNS’ central role in Treg maturation. Essentially, these are cells capable of constraining inflammation – even though IκBNS in no way influences the function of regulatory T cells,” explains Dr. Marc Schuster, one of Schmitz’ colleagues at HZI and the article’s first author. The researchers tested their hypothesis regarding IκBNS’ central role in Treg development in mice that are missing this factor. Since cells that lack IκBNS do not “become cops,” the immune system’s effector cells are undamped and could trigger chronic inflammation of the intestine. 

The results have confirmed that further research on IκBNS is of interest from a medical perspective as well. On the one hand, it allows predicting diseases: If IκBNS is fraught with errors, this could trigger autoimmune disorders.

On the other hand, one potential therapeutic goal might be “to manipulate IκBNS in such a way that we can control the number of Tregs,” explains Schmitz, who, in addition to his HZI research, also has a chair at the Otto von Guericke University Magdeburg. “IκBNS stabilization could benefit autoimmune disease therapy. As far as infections or tumors are concerned, we would need to inhibit IκBNS to decrease the number of regulatory T cells. Of course, all that is still in the very distant future.” But because IκBNS also plays an important role in effector cell activation, an intervention might have unforeseen consequences. “This is a challenge you face with many different therapeutic targets,” adds Schmitz.

Original publication:

Marc Schuster, Rainer Glauben, Carlos Plaza-Sirvent, Lisa Schreiber, Michaela Annemann, Stefan Floess, Anja A. Kühl, Linda K. Clayton, Tim Sparwasser, Klaus Schulze-Osthoff, Klaus Pfeffer, Jochen Huehn, Britta Siegmund, Ingo Schmitz
The atypical NFκB inhibitor IκBNS mediates regulatory T cell development by regulating Foxp3 induction
Immunity, 2012

——————————————

Modeling an autism risk factor in mice leads to permanent immune dysregulation.

http://www.ncbi.nlm.nih.gov/pubmed/22802640

Increasing evidence highlights a role for the immune system in the pathogenesis of autism spectrum disorder (ASD), as immune dysregulation is observed in the brain, periphery, and gastrointestinal tract of ASD individuals.

Furthermore, maternal infection (maternal immune activation, MIA) is a risk factor for ASD. Modeling this risk factor in mice yields offspring with the cardinal behavioral and neuropathological symptoms of human ASD. In this study, we find that offspring of immune-activated mothers display altered immune profiles and function, characterized by a systemic deficit in CD4(+) TCRβ(+) Foxp3(+) CD25(+) T regulatory cells, increased IL-6 and IL-17 production by CD4(+) T cells, and elevated levels of peripheral Gr-1(+) cells. In addition, hematopoietic stem cells from MIA offspring exhibit altered myeloid lineage potential and differentiation.

Interestingly, repopulating irradiated control mice with bone marrow derived from MIA offspring does not confer MIA-related immunological deficits, implicating the peripheral environmental context in long-term programming of immune dysfunction. Furthermore, behaviorally abnormal MIA offspring that have been irradiated and transplanted with immunologically normal bone marrow from either MIA or control offspring no longer exhibit deficits in stereotyped/repetitive and anxiety-like behaviors, suggesting that immune abnormalities in MIA offspring can contribute to ASD-related behaviors.

These studies support a link between cellular immune dysregulation and ASD-related behavioral deficits in a mouse model of an autism risk factor.

Advertisements
This entry was posted in Autism, co-morbid, Environment, Epigenetics, Genetics, Immune System, Inflammation, Mice, Neurology, Physiology, Treatment and tagged , , , , , , , , , , , . Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s